Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review.
Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review.
复制标题
轻度疾病患者的急性后和长期covid-19症状:系统评价。
DOI:
10.1093/fampra/cmab076
复制
发表时间:
2022-01-19
期刊:
影响因子:
2.2
通讯作者:
van Jaarsveld CHM
中科院分区:
文献类型:
--
作者:
van Kessel SAM;Olde Hartman TC;Lucassen PLBJ;van Jaarsveld CHM
It is expected that GPs are increasingly confronted with a large group of patients with symptoms persisting three weeks after initial symptoms of a mild (managed in the outpatient setting) COVID-19 infection. Currently, research on these persistent symptoms mainly focuses on patients with severe infections (managed in an inpatient setting) whereas patients with mild disease are rarely studied. The main objective of this systematic review was to create an overview of the nature and frequency of persistent symptoms experienced by patients after mild COVID-19 infection. Systematic literature searches were performed in Pubmed, Embase and PsychINFO on 2 February 2021. Quantitative studies, qualitative studies, clinical lessons and case reports were considered eligible designs. In total, nine articles were included in this literature review. The frequency of persistent symptoms in patients after mild COVID-19 infection ranged between 10% and 35%. Symptoms persisting after a mild COVID-19 infection can be distinguished into physical, mental and social symptoms. Fatigue was the most frequently described persistent symptom. Other frequently occurring persistent symptoms were dyspnoea, cough, chest pain, headache, decreased mental and cognitive status and olfactory dysfunction. In addition, it was found that persisting symptoms after a mild COVID-19 infection can have major consequences for work and daily functioning. There is already some evidence that symptoms of mild COVID-19 persist after 3 weeks in a third of patients. However, there is a lack of data about symptoms persisting after 3 months (long-COVID). More research is needed to help GPs in managing long-COVID.
登录
查看更多内容
影响因子:
3.4
作者:
D'Ascanio, Luca;Pandolfini, Manlio;Di Stadio, Arianna
通讯作者:
Di Stadio, Arianna
影响因子:
4.3
作者:
Lau HM;Lee EW;Wong CN;Ng GY;Jones AY;Hui DS
通讯作者:
Hui DS
影响因子:
--
作者:
Kingstone, Tom;Taylor, Anna K;Chew-Graham, Carolyn A
通讯作者:
Chew-Graham, Carolyn A
影响因子:
--
作者:
Hickie, Ian;Davenport, Trace;Lloyd, Andrew
通讯作者:
Lloyd, Andrew
DOI:
10.1177/070674370705200405
发表时间:
2007-04-01
影响因子:
4
作者:
Lee, Antoinette M.;Wong, Josephine G. W. S.;Chua, Siew E.
通讯作者:
Chua, Siew E.